• 분석과학
• /
• 제9권1호
• /
• pp.91-97
• /
• 1996

수계에서 화학물질의 독성에 대한 humic acid(HA)의 영향을 예측하기 위하여 HA와 화학물질간의 결합상수($K_B$)를 equilibrium dialysis를 이용하여 cartap, diazinon, fenobucarb, pentachlorophenol, P,P'-DDT를 대상으로 측정하였다. $K_B$의 실험치 및 옥탄올/물 분배계수를 이용한 예측치로부터 대상 화합물 중 P,P'-DDT를 제외하고는 HA에 의해 수계 독성에 영향을 줄만한 농도의 감소는 없을 것으로 추정되었다. 실제 자연환경에서는 $K_B{\geq}10^5$ 또는 $K_{ow}{\geq}10^6$ (log $K_{ow}{\geq}6$)인 화학물질에 대해서만 HA에 의한 독성감소 효과를 기대할 수 있는 것으로 생각 되었다.

• Animal cells and systems
• /
• 제1권1호
• /
• pp.77-80
• /
• 1997

DOantrolene is a primary specific therapeutic drug for prevention and treatment of malignant hyperthermia symptoms. The mechanisms underlying the therapeutic effects of the drug are not well understood. The present study aimed at the characterization of the effects of azumolene, a water soluble dantrolene analogue, on ryanodine binding to sarcoplasmic reticulum (SR) from normal and malign::lnt hyperthermia susceptible (MHS) swine muscles. Characteristics of $[^3H]ryanodine$ binding were clearly different between the two types of SR. Kinetic analysis of eH]ryanodine binding to SR in the presence of $2{\mu}M$ $Ca^{2+}$ showed that association constant $(K_{ryanodine}_7$ is significantly higher in MHS than normal muscle SR $(2.83 vs. 1.32{\times}10^7 M^{-1}$, whereas the maximal ryanodine binding capacity $(B_{max})$ is similar between the two types of SR. Addition of azumolene $(e.g. 400{\mu}M)$ did not significantly alter both $K_{ryanodine}$ and $B_{max}$ of $[^3H]$ryanodine binding in both types of SR, indicating that the azumolene effect was not on the ryanodine binding sites. Addition of caffeine activated $[^3H]$ ryanodine binding in both types of SR, and caffeine sensitivity was significantly higher in MHS muscle SR than normal muscle SR $(K_{caffeine}:3.24 vs. 0.82 {\times} 10^2 M^{-l}). Addition of azumolene $(e.g.400{\mu}M)$ decreased Kcaffeine without significant change in $B_{max}$ in both types of SR suggesting that azumolene competes with caffeine binding site(s). These results suggest that malignant hyperthermia symptoms are caused at least in part by greater sensitivity of the MHS muscle SR to the $Ca^{2+}$ release drug(s), and that azumolene can reverse the symptoms by reducing the drug affinity to $Ca^{2+}$ release channels.